Evidence map›Paper›PMID 37828617›Full record

ArticleResearch involvement and engagement2023

Co-creation of the Global Patient Experience Data Navigator: a multi-stakeholder initiative to ensure the patient voice is represented in health decision-making.

Tom Willgoss, Omar A Escontrias, Carole Scrafton, Elisabeth Oehrlein, Victoria Livingstone, Fiona C Chaplin, Maddalena Benivento, Hayley Chapman, Nicholas Brooke

Abstract read
In one paragraph

Article in Research involvement and engagement, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tom WillgossPatient Centered Outcomes Research, Roche, Hexagon Place, Falcon Way, Welwyn Garden City, UK. tom.willgoss@roche.com.
Omar A EscontriasEscontrías, National Health Council, 1730 M St. NW, Suite 650, Washington, DC, 20036, USA.
Carole ScraftonFlutters and Strutters Patient Advocacy Organisation, Sunderland, UK.
Elisabeth OehrleinApplied Patient Experience, LLC, 2201 Wisconsin Ave NW, Suite 200, Washington, DC, 20007, USA.
Victoria LivingstoneGlobal Patient Engagement, Medical Affairs, Gilead Sciences Europe Ltd, Roundwood Avenue, Stockley Park, Uxbridge, UK.
Fiona C ChaplinTwist Medical Ltd, 125 Howard Avenue, Suite 530, Burlingame, CA, 94010, USA.
Maddalena BeniventoPatient Focused Medicines Development (PFMD), The Synergist, Avenue Louise 231, 1000, Brussels, Belgium.
Hayley ChapmanPatient Focused Medicines Development (PFMD), The Synergist, Avenue Louise 231, 1000, Brussels, Belgium. hayley@thesynergist.org.
Nicholas BrookePatient Focused Medicines Development (PFMD), The Synergist, Avenue Louise 231, 1000, Brussels, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPutting patients' needs and priorities at the forefront of healthcare initiatives and medical product development is critical to achieve outcomes that matter most to patients. This relies on the integration of early, meaningful patient engagement (PE) to learn what is important to patients, and collection of representative patient experience data (PXD). The increased number of PE/PXD efforts across global regulatory, health technology assessment, and healthcare systems is an important step forward to deliver improved health outcomes for patients. However, these initiatives are fragmented and lack integration, which is necessary to maximize efforts and reduce burden on patients. To overcome these challenges, the Global Patient Experience Data Navigator has been co-created by Patient Focused Medicines Development to provide practical resources that can facilitate and optimize PXD generation, collection, analysis, and dissemination for patient benefit and aims to be applicable across all therapeutic areas for all stakeholders.

methodsCo-creation of the Navigator took place through an iterative process of validation and formalization driven by a diverse, multi-stakeholder working group with individuals who have varying knowledge/experience in PE/PXD.

resultsA series of workshops took place to conduct a gap analysis, develop a taxonomy model, and integrate existing frameworks. The collective insights led to the development of the Navigator consisting of four specific tools in the form of downloadable templates, which can be used to: (1) prioritize outcomes that matter most to patients and their caregivers; (2) select appropriate measurement methods for these outcomes; (3) identify when and why PXD is used throughout the product development cycle for each stakeholder; (4) identify when and why PXD is used throughout the healthcare process for each stakeholder. A public consultation was carried out to collect user feedback before the Navigator was made publicly available in December 2022.

conclusionTo our knowledge, the Global Patient Experience Data Navigator is the only publicly available toolkit developed with a multi-stakeholder and disease-agnostic approach providing taxonomically grouped resources to optimize the collection and collation of PXD for patient benefit. Future work will aim to further engage patients by adding a PE dimension to the Navigator.

Indexed as

HealthcareMedical, pharmaceutical, and technology developmentPatient-centered carePatient engagementPatient experience dataPatient-generated dataPatient-preference studiesPatient-reported outcomesPublic and patient involvement

Identifiers

PMID37828617
PMCPMC10571339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.